ORA non-exec adds to stake

An ORA Capital Partners non-exec has invested more than £15,000 in the company. James Ede-Golightly bought 19,176 shares for his SIPP at 80p each. This takes his stake in AIM-quoted ORA to 199,176 shares. Cambridge graduate Ede-Golightly is a former analyst with Merrill Lynch and Commerzbank. ORA is an investment company specialising in taking significant stakes in developing companies. It has developed five main businesses: Nanoco, Oxford Advanced Surfaces, Tissue Regenix, Oxford Nutrascience and Obtala Resources. All of these are quoted on AIM. ORA also has a stake in broker Novum Securities. ORA reported a fall in interim profit from £22.2m to £11.5m in the six months to July 2010. The net asset value fell slightly from £127m to £124.8m having bought back £13.7m worth of shares at 100p each. Top Director BuysORA Capital Partners Ltd. (ORA) Director name: Mr James Ede-GolightlyAmount purchased: 19,176 @ 80.00p Value: £15,341Top Director SellsGoodwin Plc (GDWN) Director name: Mr John W GoodwinAmount sold: 12,946 @ 1,230.00p Value: £159,236Goodwin Plc (GDWN) Director name: Mr Richard S GoodwinAmount sold: 8,478 @ 1,230.00p Value: £104,279Goodwin Plc (GDWN) Director name: Mr Richard S GoodwinAmount sold: 8,478 @ 1,230.00p Value: £104,279Goodwin Plc (GDWN) Director name: Mr Matthew Stanley GoodwinAmount sold: 6,270 @ 1,230.00p Value: £77,121AG Barr (BAG) Director name: Mr Jonathan D KempAmount sold: 3,000 @ 1,203.50p Value: £36,105 Barr (A.G.) Goodwin